ABOUT US

Worldwide Healthcare Investing

Exome Asset Management is an innovative asset management company focused on investing in public markets across the worldwide healthcare industry. Rapid change and technological advances in the healthcare industry have created an exquisite palette of investment opportunities on a worldwide basis, which we believe shapes a compelling investment thesis.

  • Pharmaceuticals

  • Biotech/Discovery

  • Life Science Tools

  • Medical Devices

  • Healthcare Services

  • Other Healthcare

Our Strategies

The firm practices two existing investment strategies: one invests in healthcare companies throughout the world, with an emphasis on the United States and other developed countries, and another that is a specialized healthcare investment strategy emphasized on public company opportunities in emerging markets.

Strategic investing in healthcare companies throughout the world, with an emphasis on the United States and other developed countries.

OUR TEAM

World-class team of global healthcare investors

Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare. Mr. Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for nearly five decades. He is supported by an exceptional team of investment professionals and support staff.

OUR TEAM

World-class team of global healthcare investors

Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare. Mr. Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for nearly five decades. He is supported by an exceptional team of investment professionals and support staff.

https://www.exomeasset.com/wp-content/uploads/2019/08/first-min.png

2018

Year Founded

100+

Positions Worldwide

$130M+

Assets Under Management1

₁ AUM as of June 30, 2020

Contact Us